60/100BNovo-Nordisk A/S reports its Q4 FY2026 results on 3 February 2027, before the market opens. Analysts expect earnings per share of 0.68 USD and revenue of 11.78B USD.
In Q3 FY2026, reported on 4 November 2026, Novo-Nordisk A/S earned 0.89 USD a share against the 0.73 USD analysts expected (+21.8%), on revenue of 11.90B USD against 11.07B USD (+7.5%).
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 0.68 | — | — | -32.00% | 11.78B | — | — | -5.75% | — | |
| Q3 FY2026 | 0.73 | 0.89 | +21.75% | -12.75% | 11.07B | 11.90B | +7.54% | +3.25% | +4.9% | |
| Q2 FY2026 | 0.82 | 0.96 | +17.07% | -1.03% | 10.89B | 12.13B | +11.40% | +1.30% | +0.8% | |
| Q1 FY2026 | 0.87 | 1.04 | +19.54% | +13.04% | 10.86B | 11.02B | +1.50% | -7.35% | +1.9% | |
| Q4 FY2025 | 0.90 | 1.00 | +11.11% | +9.89% | 12.13B | 12.50B | +3.10% | +5.44% | -14.7% | |
| Q3 FY2025 | 0.77 | 1.02 | +32.47% | +15.91% | 11.94B | 11.53B | -3.47% | +7.93% | +0.5% | |
| Q2 FY2025 | 0.93 | 0.97 | +4.30% | +47.64% | 11.92B | 11.97B | +0.43% | +22.19% | -3.9% | |
| Q1 FY2025 | 0.92 | 0.92 | 0.00% | +12.33% | 11.70B | 11.90B | +1.73% | +26.78% | +1.9% | |
| Q4 FY2024 | 0.88 | 0.91 | +3.41% | +28.17% | 11.55B | 11.86B | +2.67% | +23.55% | +3.8% | |
| Q3 FY2024 | 0.87 | 0.88 | +1.38% | +20.55% | 10.48B | 10.68B | +1.89% | +27.86% | -4.4% | |
| Q2 FY2024 | 0.70 | 0.66 | -5.87% | +4.29% | 10.04B | 9.80B | -2.43% | +22.06% | -8.4% | |
| Q1 FY2024 | 0.74 | 0.82 | +10.53% | +30.00% | 9.07B | 9.38B | +3.45% | +19.09% | -4.0% | |
| Q4 FY2023 | 0.66 | 0.71 | +7.58% | +73.17% | 9.15B | 9.60B | +4.87% | +38.44% | +5.2% | |
| Q3 FY2023 | 0.69 | 0.73 | +5.80% | +69.77% | 8.17B | 8.35B | +2.24% | +38.25% | +3.3% | |
| Q2 FY2023 | 0.67 | 0.63 | -5.97% | +50.00% | 8.21B | 8.03B | -2.16% | +42.95% | -2.9% | |
| Q1 FY2023 | 0.63 | 0.63 | 0.00% | +34.04% | 7.66B | 7.88B | +2.90% | +32.19% | -4.4% | |
| Q4 FY2022 | 0.41 | 0.41 | 0.00% | +10.81% | 6.84B | 6.93B | +1.39% | +19.10% | +0.2% | |
| Q3 FY2022 | 0.42 | 0.43 | +2.38% | +2.38% | 5.89B | 6.04B | +2.52% | +8.74% | +6.4% | |
| Q2 FY2022 | 0.44 | 0.42 | -4.55% | -2.33% | 5.73B | 5.62B | -2.01% | +6.64% | -12.6% | |
| Q1 FY2022 | 0.43 | 0.47 | +9.30% | +6.82% | 5.77B | 5.96B | +3.37% | +11.61% | +3.3% | |
| Q4 FY2021 | 0.35 | 0.37 | +5.71% | +15.63% | 5.76B | 5.82B | +1.06% | +10.32% | +3.9% | |
| Q3 FY2021 | 0.40 | 0.42 | +5.00% | +23.53% | 842.24M | 5.56B | +559.88% | +14.03% | +5.0% | |
| Q2 FY2021 | 0.38 | 0.43 | +13.16% | +26.47% | 5.09B | 5.27B | +3.53% | +16.35% | +5.5% | |
| Q1 FY2021 | 0.40 | 0.44 | +10.00% | +15.79% | 5.12B | 5.34B | +4.33% | +8.32% | -0.1% | |
| Q4 FY2020 | 0.29 | 0.32 | +10.34% | +14.29% | 5.11B | 5.28B | +3.19% | +7.24% | +2.1% | |
| Q3 FY2020 | 0.34 | 0.34 | 0.00% | +6.25% | 4.96B | 4.87B | -1.77% | +9.82% | -3.8% | |
| Q2 FY2020 | 0.32 | 0.34 | +6.25% | +9.68% | 5.19B | 4.53B | -12.83% | -0.81% | -2.1% | |
| Q1 FY2020 | 0.37 | 0.38 | +2.70% | +15.15% | 3.94B | 4.93B | +25.07% | +11.93% | -2.1% | |
| Q4 FY2019 | 0.28 | 0.28 | 0.00% | +3.70% | 4.75B | 4.92B | +3.56% | +3.14% | +4.5% | |
| Q3 FY2019 | 0.31 | 0.32 | +3.23% | +10.34% | 4.36B | 4.44B | +1.78% | +2.32% | +2.2% | |
| Q2 FY2019 | 0.31 | 0.31 | 0.00% | -8.82% | 4.46B | 4.56B | +2.23% | +6.97% | +0.1% | |
| Q1 FY2019 | 0.31 | 0.33 | +6.45% | -10.81% | 4.10B | 4.40B | +7.37% | -1.04% | -2.8% | |
| Q4 FY2018 | 0.28 | 0.27 | -3.57% | +3.85% | 4.80B | 4.77B | -0.59% | +8.22% | +3.4% | |
| Q3 FY2018 | 0.29 | 0.29 | 0.00% | -6.45% | 4.44B | 4.34B | -2.28% | +3.07% | +1.6% | |
| Q2 FY2018 | 0.32 | 0.34 | +6.25% | +17.24% | 4.04B | 4.27B | +5.73% | -2.74% | -6.2% | |
| Q1 FY2018 | 0.34 | 0.37 | +8.82% | +27.59% | 4.07B | 4.45B | +9.25% | +8.69% | +2.8% | |
| Q4 FY2017 | 0.28 | 0.26 | -7.14% | +4.00% | 5.08B | 4.41B | -13.25% | +5.68% | -6.6% | |
| Q3 FY2017 | 0.29 | 0.31 | +6.90% | +6.90% | 4.02B | 4.21B | +4.65% | +1.54% | -0.3% | |
| Q2 FY2017 | 0.28 | 0.29 | +3.57% | -3.33% | 4.60B | 4.39B | -4.67% | +6.99% | -1.0% | |
| Q1 FY2017 | 0.26 | 0.29 | +11.54% | +3.57% | 3.79B | 4.10B | +8.03% | -1.28% | +5.6% | |
| Q4 FY2016 | 0.26 | 0.25 | -3.85% | +8.70% | 4.19B | 4.17B | -0.45% | -0.93% | -8.8% | |
| Q3 FY2016 | 0.28 | 0.29 | +3.57% | +16.00% | 3.90B | 4.14B | +6.40% | +3.09% | -12.9% | |
| Q2 FY2016 | 0.29 | 0.30 | +3.45% | +25.00% | 4.04B | 4.10B | +1.57% | +1.98% | -9.6% | |
| Q1 FY2016 | 0.26 | 0.28 | +7.69% | +27.27% | 4.16B | 4.15B | -0.28% | +13.33% | -0.4% | |
| Q4 FY2015 | 0.24 | 0.23 | -4.17% | +21.05% | 4.21B | 4.21B | -0.09% | -1.61% | -6.1% | |
| Q3 FY2015 | 0.23 | 0.25 | +8.70% | +19.05% | 3.78B | 4.02B | +6.36% | +6.58% | -6.7% | |
| Q2 FY2015 | — | 0.24 | — | 0.00% | — | 4.02B | — | +1.78% | -3.6% | |
| Q1 FY2015 | 0.19 | 0.22 | +15.79% | 0.00% | — | 3.66B | — | -2.16% | +1.2% | |
| Q4 FY2014 | — | 0.19 | — | -9.52% | — | 4.28B | — | +11.04% | -3.0% | |
| Q3 FY2014 | — | 0.21 | — | -4.55% | — | 3.77B | — | +1.11% | +6.2% | |
| Q2 FY2014 | — | 0.24 | — | +9.09% | — | 3.95B | — | +5.95% | -2.3% | |
| Q1 FY2014 | 0.22 | 0.22 | 0.00% | +15.79% | 3.69B | 3.74B | +1.42% | +9.03% | -2.9% | |
| Q4 FY2013 | — | 0.21 | — | +10.53% | — | 3.85B | — | +6.34% | +2.9% | |
| Q3 FY2013 | — | 0.22 | — | +22.22% | — | 3.73B | — | +8.98% | -8.0% | |
| Q2 FY2013 | — | 0.22 | — | — | — | 3.73B | — | — | 0.0% | |
| Q1 FY2013 | — | 0.19 | — | +271.67% | — | 3.43B | — | +8.20% | -2.5% | |
| Q4 FY2012 | — | 0.19 | — | +259.30% | — | 3.62B | — | +14.32% | -0.4% | |
| Q3 FY2012 | — | 0.18 | — | +241.88% | — | 3.42B | — | +14.63% | -0.6% | |
| Q1 FY2012 | 0.05 | 0.05 | -3.35% | — | 3.23B | 3.17B | -1.93% | — | +1.7% | |
| Q4 FY2011 | 0.05 | 0.05 | +15.38% | +15.53% | 2.70B | 3.17B | +17.30% | +10.76% | +4.1% | |
| Q3 FY2011 | 0.05 | 0.05 | +7.69% | +35.17% | 2.87B | 2.99B | +4.08% | +4.84% | +8.2% | |
| Q2 FY2011 | 0.06 | 0.14 | +153.95% | — | 3.15B | 3.10B | -1.52% | — | -7.0% | |
| Q4 FY2010 | 0.05 | 0.05 | -7.40% | — | 3.17B | 2.86B | -9.72% | — | -1.8% | |
| Q3 FY2010 | 0.04 | 0.04 | -4.53% | — | 3.02B | 2.85B | -5.72% | — | +0.7% | |
| Q3 FY2006 | 0.02 | 0.02 | +11.14% | — | 1.45B | 1.63B | +12.80% | — | -3.4% | |
| Q2 FY2006 | 0.02 | 0.02 | 0.00% | — | 1.67B | 1.65B | -1.13% | — | +6.4% | |
| Q1 FY1997 | 0.00 | 0.01 | +150.29% | — | — | 611.09M | — | — | 0.0% | |
| Q4 FY1994 | 0.00 | 0.01 | +99.42% | — | — | 567.87M | — | — | +0.5% | |
| Q3 FY1994 | 0.00 | 0.01 | +222.67% | — | — | 599.30M | — | — | +5.6% | |
| Q1 FY1993 | — | 0.01 | — | — | — | 442.46M | — | — | +0.6% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 3.62 | — | — | +8.13% | 49.34B | — | — | +5.93% |
| FY2027 | 3.34 | — | — | -1.38% | 46.58B | — | — | +1.80% |
| FY2026 | 3.39 | — | — | -13.28% | 45.75B | — | — | -4.49% |
| FY2025 | 3.70 | 3.91 | +5.74% | +19.72% | 48.38B | 47.90B | -0.99% | +14.81% |
| FY2024 | 3.13 | 3.27 | +4.20% | +20.96% | 39.71B | 41.72B | +5.08% | +23.22% |
| FY2023 | 2.68 | 2.70 | +0.66% | +56.07% | 33.59B | 33.86B | +0.81% | +37.91% |
| FY2022 | 1.75 | 1.73 | -1.19% | +4.22% | 25.29B | 24.55B | -2.91% | +11.68% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
Meeting the target would show whether sales of weight-loss and diabetes medicines are stabilizing, excluding currency swings and one-time items.
On average, analysts' EPS estimate was 11.3% off the result, either way, and their revenue estimate 3.7%, over the last 12 quarters.
See also:Forecast,EPS,Income statement
Source: Financial Modeling PrepVerified against SEC filings
We value your privacy
We use cookies to enhance your experience and analyze site traffic. By continuing, you agree to our use of cookies. Privacy Policy
